Cartesian Growth Corporation II Stock (NASDAQ:RENE)

Ownership Financials Chart

Previous Close

$11.75

52W Range

$11.05 - $11.95

50D Avg

$11.88

200D Avg

$11.68

Market Cap

$154.51M

Avg Vol (3M)

$50.71K

Beta

-0.01

Div Yield

-

RENE Company Profile

Cartesian Growth Corporation II's principal aim is to engage in strategic corporate transactions, such as mergers, share exchanges, asset acquisitions, equity purchases, reorganizations, or other comparable business integrations with various companies or entities. This firm was established in 2021 and maintains its headquarters in New York, New York.

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Jul 08, 2022

Website

RENE Performance

RENE Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	$-931.46K	$-1.04M	$-2.03M
Net Income	$-1.51M	$8.21M	$11.44M
EBITDA	$-931.46K	$8.21M	$11.44M
Basic EPS	$-0.12	$0.56	$0.41
Diluted EPS	$-0.12	$0.56	$0.41

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
ICU	SeaStar Medical Holding Corporation